Sorafenib kills liver cancer cells by disrupting SCD1‐mediated synthesis of monounsaturated fatty acids <i>via</i> the ATP‐AMPK‐mTOR‐SREBP1 signaling pathway

Ge Liu, Chaomin Sun, Shan Kuang et al.|The FASEB Journal|2019

Cited by 122